What is the recommended assessment and management for a patient presenting with acute infectious diarrhea, including evaluation of dehydration severity, rehydration strategy, use of anti‑motility agents, indications for antibiotics, and criteria for hospitalization?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Acute Infectious Diarrhea

Begin immediate oral rehydration with reduced-osmolarity ORS (65–70 mEq/L sodium, 75–90 mmol/L glucose) for all patients with acute watery diarrhea; empiric antibiotics are not indicated in immunocompetent adults without fever, bloody stools, or recent international travel. 1

Assess Dehydration Severity

Classify dehydration to guide fluid strategy: 1

  • Mild (3–5% deficit): Slight thirst, mildly dry mucous membranes 1
  • Moderate (6–9% deficit): Loss of skin turgor, skin tenting on pinch, dry mucous membranes, decreased urine output 1, 2
  • Severe (≥10% deficit): Altered mental status, prolonged skin tenting (>2 seconds), cool extremities, decreased capillary refill, rapid deep breathing (acidosis), shock 1, 2

Rapid deep breathing, prolonged skin retraction, and poor perfusion are more reliable predictors of significant dehydration than sunken fontanelle or absence of tears. 1

Rehydration Strategy

Mild-to-Moderate Dehydration

  • Administer reduced-osmolarity ORS (≈65–70 mEq/L sodium, 75–90 mmol/L glucose) immediately 1, 2
  • Dose: 50 mL/kg for mild dehydration or 100 mL/kg for moderate dehydration over 2–4 hours 1, 2
  • Total daily fluid prescription: 2,200–4,000 mL/day, matching ongoing losses (urine + 30–50 mL/h insensible + stool losses) 1
  • Continue ORS until clinical dehydration resolves and diarrhea stops 1, 2
  • Replace each watery stool with 10 mL/kg ORS and each vomiting episode with 2 mL/kg ORS 2
  • For patients unable to drink, nasogastric delivery of ORS is acceptable 2, 3

Severe Dehydration or ORS Failure

  • Switch immediately to isotonic IV fluids (lactated Ringer's or normal saline) for: 1, 2
    • Severe dehydration (≥10% deficit)
    • Altered mental status
    • Inability to tolerate oral intake
    • Shock (hypotension, tachycardia, poor perfusion)
    • Prolonged skin tenting >2 seconds with cool extremities
  • Maintain IV rehydration until pulse, perfusion, and mental status normalize, then transition to ORS to replace remaining deficit 1, 2

Identify Red Flags Requiring Antibiotics

Do NOT prescribe empiric antibiotics for uncomplicated watery diarrhea in stable, immunocompetent adults without recent international travel. 1, 2

Situations Requiring Antibiotics

  • Fever ≥38.5°C with bloody or mucoid stools (suggests invasive pathogens: Shigella, Campylobacter, invasive E. coli) 1, 2
  • Recent international travel with severe, incapacitating symptoms 1
  • Immunocompromised patients with severe illness 1, 2
  • Signs of sepsis (altered mental status, hypotension, tachycardia) 1
  • Ill-appearing infants <3 months 1

Antibiotic Regimen (when indicated)

  • First-line: Azithromycin 1
    • 500 mg single dose for watery diarrhea
    • 1,000 mg single dose for febrile dysentery
  • Second-line: Fluoroquinolones (if azithromycin unavailable or local susceptibility favorable) 1
    • Ciprofloxacin 750 mg single dose or 500 mg BID × 3 days
    • Levofloxacin 500 mg single dose or daily × 3 days

Critical Antibiotic Contraindication

NEVER use antibiotics for suspected or confirmed Shiga-toxin-producing E. coli (STEC O157:H7 or toxin-2 producers)—antibiotics markedly increase the risk of hemolytic-uremic syndrome. 1, 2, 3

  • Screen for STEC with Shiga-toxin testing before starting antibiotics in any patient with bloody diarrhea without fever or with severe abdominal cramping 1

Antimotility Therapy (Loperamide)

  • Loperamide may be used ONLY after adequate rehydration in immunocompetent adults with watery diarrhea 1, 2
  • Dosing: 4 mg initially, then 2 mg after each loose stool (maximum 16 mg/24 hours) 1

Absolute Contraindications to Loperamide

  • Children <18 years 1, 2, 3
  • Fever present 1, 2, 3
  • Bloody stools 1, 2, 3
  • Suspected inflammatory or invasive diarrhea (risk of toxic megacolon) 1, 2, 3

Dietary Management

  • Resume normal, age-appropriate diet immediately during or after rehydration 1, 2
  • Start with small, light meals; avoid fatty, heavy, spicy foods and caffeine initially 1
  • Continue breastfeeding throughout the illness in infants 2, 3
  • Do not withhold food—early refeeding prevents malnutrition and may reduce stool output 2

Adjunctive Therapies

  • Ondansetron may be given to children >4 years and adults with vomiting to facilitate oral rehydration 2, 3
  • Probiotics may be offered to reduce symptom severity and duration (weak recommendation, moderate evidence) 1, 2

Indications for Diagnostic Testing

Reserve stool studies for: 1, 4, 5

  • Fever with bloody or mucoid stools
  • Severe dehydration or illness
  • Persistent fever
  • Immunosuppression
  • Suspected outbreak
  • Recent hospitalization or antibiotic exposure (evaluate for C. difficile)

Stool panel should include: 1

  • Bacterial culture (Salmonella, Shigella, Campylobacter, Yersinia)
  • Shiga-toxin testing (or gene detection) to identify STEC
  • C. difficile toxin assay when recent healthcare exposure or antibiotics noted

Blood cultures indicated for: 1

  • Infants <3 months
  • Signs of septicemia
  • Suspected enteric fever
  • Immunocompromised patients with systemic manifestations

Hospitalization Criteria

Admit patients with: 2, 6

  • Severe dehydration requiring IV fluids
  • Altered mental status or toxic appearance
  • Shock or hemodynamic instability
  • Inability to tolerate oral intake despite ORS attempts
  • Immunocompromised status with severe illness

Critical Pitfalls to Avoid

  • Never prioritize antimotility agents or antibiotics over rehydration—dehydration, not diarrhea, drives morbidity and mortality 1, 3
  • Never start antibiotics for bloody diarrhea before ruling out STEC with Shiga-toxin testing 1, 2
  • Never use loperamide when fever or bloody stools are present 1, 2, 3
  • Never prescribe empiric antibiotics for uncomplicated watery diarrhea—this promotes antimicrobial resistance without clinical benefit 1, 2
  • Never delay IV rehydration in severe dehydration while attempting oral rehydration 1, 2
  • Never use sports drinks, apple juice, or soft drinks for rehydration—incorrect osmolarity worsens electrolyte imbalances 3
  • Never withhold ORS in favor of IV fluids for mild-to-moderate dehydration—ORS is equally effective and avoids IV complications 3

Reassessment

  • Reassess hydration status 2–4 hours after initiating rehydration therapy 2
  • If no clinical improvement within 48–72 hours, reassess for antimicrobial resistance, fluid/electrolyte disturbances, or non-infectious etiologies and consider hospitalization 1

References

Guideline

Guideline Recommendations for Acute Watery Diarrhea in Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Recommendations for Acute Diarrhea Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Diarrhea in the Emergency Department

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Clinical Management of Infectious Diarrhea.

Reviews on recent clinical trials, 2020

Research

Acute diarrhea.

American family physician, 2014

Research

Severe acute diarrhea.

Gastroenterology clinics of North America, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.